Anna Wu, Ph.D.

Anna M. Wu, Ph.D, is professor and chair of the Department of Molecular Imaging and Therapy, and co-director, Center for Theranostics within the Diabetes Metabolism Research Institute and professor in the Department of Radiation Oncology at City of Hope in Duarte, California. She also holds the title of research professor, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, where she previously served as professor and vice chair. While at UCLA, she also held positions as director, Cancer Molecular Imaging Program, Jonsson Comprehensive Cancer Center, and co-associate director, Crump Institute for Molecular Imaging. She is a past chair of the California Breast Cancer Research Council, and fellow and past president of the World Molecular Imaging Society.

 

Dr. Wu is the co-founder and chief scientific advisor to ImaginAb Inc., an LA-based startup company which develops and commercializes engineered antibodies for clinical imaging in cancer and other diseases. Dr. Wu began her independent research career as an assistant research scientist at Beckman Research Institute of City of Hope and advanced to the position of professor of molecular biology in 2002. Dr. Wu received her A.B. degree in biochemical sciences from Harvard University, and a Ph.D. from Yale University in molecular biophysics and biochemistry (MB&B). Postdoctoral studies were conducted at Yale University (MB&B) and at University of California San Francisco in the Department of Biochemistry and Biophysics.